Update on rheumatic manifestations of infectious diseases

被引:20
作者
Becker, Jennifer [1 ]
Winthrop, Kevin L. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Arthrit & Rheumat Dis, Portland, OR 97239 USA
关键词
arthritis; bacteria; infection; vasculitis; virus; CITRULLINATED PEPTIDE ANTIBODIES; HUMAN PARVOVIRUS B19; HEPATITIS-C; REACTIVE ARTHRITIS; ENTERIC PATHOGENS; VIRUS; MEASLES; CHIKUNGUNYA; PERSISTENCE; SYMPTOMS;
D O I
10.1097/BOR.0b013e328333b9f5
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Purpose of review As infectious diseases continue to emerge, and as molecular techniques advance, the rheumatic manifestations of infectious diseases are increasingly recognized and better understood. Herein, we review important recent clinical, epidemiologic, and basic science advances within this area of rheumatology. Recent findings We searched the U.S. National Library of Medicine PubMed database for relevant articles published since 1 January 2008. We identified a number of studies suggesting a potentially greater role for persistent viral and bacterial infections in the development of rheumatoid arthritis or rheumatoid arthritis-like syndromes. These include emerging pathogens like Chikungunya virus, as well as historically important pathogens like measles. New literature furthers the idea that antecedent infections with Chlamydia sp. could be causative in some cases of undifferentiated spondyloarthritis. Other studies document diagnostic methods capable of distinguishing between Hepatitis C virus and auto-immune driven arthritis allowing clinicians to better target therapy. Summary Infectious pathogens are increasingly recognized in association with rheumatic disease. Rheumatologists should be aware of this trend as such recognition may alter the diagnosis and management of rheumatic symptoms, as well as trigger new research opportunities to better understand the causes of rheumatic disease.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 40 条
[1]
Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement [J].
Bombardieri, M ;
Alessandri, C ;
Labbadia, G ;
Iannuccelli, C ;
Carlucci, F ;
Riccieri, V ;
Paoletti, V ;
Valesini, G .
ARTHRITIS RESEARCH & THERAPY, 2004, 6 (02) :R137-R141
[2]
[3]
Emerging word infections and arthritis: the role of the rheumatologist [J].
Calabrese, Leonard H. .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (01) :2-3
[4]
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection [J].
Calabrese, LH ;
Zein, N ;
Vassilopoulos, D .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 :18-24
[5]
Carmona RJ, 2008, J RHEUMATOL, V35, P935
[6]
Reactive Arthritis: Clinical Aspects and Medical Management [J].
Carter, John D. ;
Hudson, Alan P. .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2009, 35 (01) :21-+
[7]
Chlamydiae as Etiologic Agents in Chronic Undifferentiated Spondylarthritis [J].
Carter, John D. ;
Gerard, Herve C. ;
Espinoza, Luis R. ;
Ricca, Louis R. ;
Valeriano, Joanne ;
Snelgrove, Jessica ;
Oszust, Cynthia ;
Vasey, Frank B. ;
Hudson, Alan P. .
ARTHRITIS AND RHEUMATISM, 2009, 60 (05) :1311-1316
[8]
Chen YS, 2006, J RHEUMATOL, V33, P887
[9]
Parvovirus B19: Its Role in Chronic Arthritis [J].
Colmegna, Ines ;
Alberts-Grill, Noah .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2009, 35 (01) :95-+
[10]
Ferri C, 2008, J RHEUMATOL, V35, P1944